The global glucuronolactonemarket is expected to reach USD 436.5
million by 2024, according to a new report by Grand View Research, Inc. Growing
consumer awareness towards the use of glucuronolactone in various food &
beverage products including energy drinks and nutrition supplements will
augment industry growth over the next eight years. Growing use of the product
for manufacturing pharmaceutical drugs and health supplement is expected to
fuel industry growth over the forecast period. The positive outlook towards
sports nutrition in light of increasing importance of active lifestyle will
promote market expansion.
Food & beverage was the prominent
end-use segment and was valued at USD 155.1 million in 2015. Rising health
conscious population in the urban region is expected to fuel demand growth over
the forecast period. Rising disposable income, increasing health awareness,
growing population in various countries including the U.S., Brazil, India and
China will promote market growth over the upcoming years.
Browse full report by Grand View
Research : http://www.grandviewresearch.com/industry-analysis/glucuronolactone-market
Further key findings from the report suggest
·
Pharmaceutical application will witness the
fastest growth at a CAGR of 7.0% from 2014 to 2024 as a result of increasing
usage of glucuronolactone based tablets and supplements to cure arthritis,
hepatocirrhosis, and hepatitis. Furthermore, recovery of pharmaceutical
industry in the U.S. is expected to drive market growth over the forecast
period.
·
North America glucuronolactone market was
valued at USD 106.7 million in 2015 and will show significant rise owing to
growing demand for energy drinks and nutritional supplements. Moreover,
adoption of glucuronolactone as a supplement is also expected to fuel demand
over the forecast period.
·
Asia Pacific will witness significant
growth at a CAGR of 6.6% from 2016 to 2024 in light of the high level of glucuronolactone
producers in China, India, and Japan with a high level of exports. Moreover,
abundant availability of the product in China is expected to have a positive
impact on the market over the coming years. Growing pharmaceutical sector in
China, India, Indonesia, Malaysia Philippines, Singapore, Thailand and Vietnam
will stimulate industry expansion.
·
Key manufacturers & exporters in the
global glucuronolactone industry include Aceto Corporation, Anhui Fubore
Pharmaceutical & Chemical Co., Ltd., Creative Compounds, LLC, Foodchem
International Corporation, Hubei Yitai Pharmaceutical Co., Ltd., Merck
Millipore Corporation, and Shaoxing Marina Biotechnology Co., Ltd.
·
Merck Millipore Corporation offers
glucuronolactone produced by glucose oxidase and used as a nutritional
supplement in pharmaceutical industries.
Browse more reports of this category by Grand View
Research: https://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements
Grand View Research has segmented the
global glucuronolactone market on the basis of end-use and region:
Global Glucuronolactone End-Use Outlook (Revenue, USD
Million, 2013 - 2024)
·
Food & Beverage
·
Pharmaceuticals
·
Others
Global Glucuronolactone Regional Outlook (Revenue, USD
Million, 2013 - 2024)
·
North America
o U.S.
·
Europe
o Germany
o UK
o France
·
Asia Pacific
o China
o India
o Japan
·
Latin America
o Brazil
·
MEA
View press
release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-glucuronolactone-market
About Grand
View Research
Grand View Research, Inc. is a U.S. based market research and consulting
company, registered in the State of California and headquartered in San
Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
No comments:
Post a Comment